May 2015 Life Science Industry Research Reports

Relapsing Remitting Multiple Sclerosis (RRMS) – Pipeline Review, H1 2015

Published in May 2015 ; US $ 2000 Onwards; Publisher: Global Markets Direct

Global Markets Direct’s, ‘Relapsing Remitting Multiple Sclerosis (RRMS) – Pipeline Review, H1 2015′, provides an overview of the Relapsing Remitting Multiple Sclerosis (RRMS)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Relapsing Remitting Multiple Sclerosis (RRMS), […]

Psoriatic Arthritis – Pipeline Review, H1 2015

Published in May 2015 ; US $ 2000 Onwards; Publisher: Global Markets Direct

Global Markets Direct’s, ‘Psoriatic Arthritis – Pipeline Review, H1 2015′, provides an overview of the Psoriatic Arthritis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Psoriatic Arthritis, complete with comparative analysis at various stages, therapeutics assessment […]

Diabetic Foot Ulcers – Pipeline Review, H1 2015

Published in May 2015 ; US $ 2000 Onwards; Publisher: Global Markets Direct

Global Markets Direct’s, ‘Diabetic Foot Ulcers – Pipeline Review, H1 2015′, provides an overview of the Diabetic Foot Ulcers’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Diabetic Foot Ulcers, complete with comparative analysis at various […]

Acinetobacter Infections – Pipeline Review, H1 2015

Published in May 2015 ; US $ 2000 Onwards; Publisher: Global Markets Direct

Global Markets Direct’s, ‘Acinetobacter Infections – Pipeline Review, H1 2015′, provides an overview of the Acinetobacter Infections’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Acinetobacter Infections, complete with comparative analysis at various stages, therapeutics assessment […]

Gouty Arthritis (Gout) – Pipeline Review, H1 2015

Published in May 2015 ; US $ 2000 Onwards; Publisher: Global Markets Direct

Global Markets Direct’s, ‘Gouty Arthritis (Gout) – Pipeline Review, H1 2015′, provides an overview of the Gouty Arthritis (Gout)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Gouty Arthritis (Gout), complete with comparative analysis at various […]

Acute Respiratory Distress Syndrome – Pipeline Review, H1 2015

Published in May 2015 ; US $ 2000 Onwards; Publisher: Global Markets Direct

Global Markets Direct’s, ‘Acute Respiratory Distress Syndrome – Pipeline Review, H1 2015′, provides an overview of the Acute Respiratory Distress Syndrome’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Acute Respiratory Distress Syndrome, complete with comparative […]

Hemophilia B – Pipeline Review, H1 2015

Published in May 2015 ; US $ 2000 Onwards; Publisher: Global Markets Direct

Global Markets Direct’s, ‘Hemophilia B – Pipeline Review, H1 2015′, provides an overview of the Hemophilia B’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hemophilia B, complete with comparative analysis at various stages, therapeutics assessment […]

Malignant Pleural Mesothelioma – Pipeline Review, H1 2015

Published in May 2015 ; US $ 2000 Onwards; Publisher: Global Markets Direct

Global Markets Direct’s, ‘Malignant Pleural Mesothelioma – Pipeline Review, H1 2015′, provides an overview of the Malignant Pleural Mesothelioma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Malignant Pleural Mesothelioma, complete with comparative analysis at various […]

Renal Anemia – Pipeline Review, H1 2015

Published in May 2015 ; US $ 2000 Onwards; Publisher: Global Markets Direct

Global Markets Direct’s, ‘Renal Anemia – Pipeline Review, H1 2015′, provides an overview of the Renal Anemia’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Renal Anemia, complete with comparative analysis at various stages, therapeutics assessment […]